Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,676 public trials 321 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Recruiting

Study on the Clinical Efficacy of Teclistamab and Talquetamab

NCT06477783

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Imelda Bonheiden, Antwerpen, Belgium
  • Universitair Ziekenhuis Antwerpen (UZA) Edegem, Antwerpen, Belgium
  • Grand Hôpital de Charleroi Charleroi, Henegouwen, Belgium
  • EpiCURA Hornu, Henegouwen, Belgium
View all 17 locations
View Trial Details
Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT07518186

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
View all 173 locations
View Trial Details
Recruiting

A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma

NCT07336472

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • City of Hope - Duarte Duarte, California, United States
  • City of Hope - Lennar Irvine, California, United States
  • Emory Atlanta, Georgia, United States
View Trial Details
Recruiting

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

NCT07095452

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Hospital Scottsdale /ID# 278349 Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center /ID# 278238 Los Angeles, California, United States
  • Colorado Blood Cancer Institute /ID# 279080 Denver, Colorado, United States
  • Winship Cancer Institute of Emory University /ID# 277667 Atlanta, Georgia, United States
View all 49 locations
View Trial Details
Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

NCT02693535

Conditions
Advanced Solid Tumors, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Cancer Treatment Centers of America-Phoenix Phoenix, Arizona, United States
  • Sutter Auburn Auburn, California, United States
  • Sutter Alta Bates Berkeley, California, United States
View all 181 locations
View Trial Details

Related conditions